PAP 2023: Corey Ford Discusses the Future of Data-Powered Patient Adherence at Access PAP 2023

The investment not only moves along the company’s efforts in advancing clinical studies, but also opens up 700 new jobs for the Greater Toronto area.

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.

Despite challenges surrounding communication overload, drug shortages, and cybersecurity risks, this term is revolutionizing medication management and patient care through the use artificial intelligence and predictive forecasting.

These medications are used to treat a multitude of conditions including type 2 diabetes, cancer and asthma.

Cryoport's business unit, Cryogene, will be tasked with helping to foster the growth of Moffitt’s cell and gene therapy efforts.

The collaboration is powered by the discovery and development of obesity, type 2 diabetes, and cardiovascular disease treatments.